Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens

Baszczyňski, O.; Černý, J.; Čmoková, A.; Grobárová, V.; Kolařík, M.; Procházková, E.; Slapničková, M.; Štěpánek, O.; Zíková, A. Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens. ChemMedChem 2022, 17 (21), nestránkováno.

Google Scholar